Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Receivables - Net (2016 - 2025)

Historic Receivables - Net for CorMedix (CRMD) over the last 12 years, with Q3 2025 value amounting to $158.6 million.

  • CorMedix's Receivables - Net rose 81200.35% to $158.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $158.6 million, marking a year-over-year increase of 81200.35%. This contributed to the annual value of $51.7 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that CorMedix reported Receivables - Net of $158.6 million as of Q3 2025, which was up 81200.35% from $42.9 million recorded in Q2 2025.
  • CorMedix's 5-year Receivables - Net high stood at $158.6 million for Q3 2025, and its period low was $2975.0 during Q1 2022.
  • Over the past 4 years, CorMedix's median Receivables - Net value was $581771.5 (recorded in 2024), while the average stood at $27.2 million.
  • Its Receivables - Net has fluctuated over the past 5 years, first plummeted by 9317.75% in 2022, then skyrocketed by 2069686.82% in 2025.
  • Quarter analysis of 4 years shows CorMedix's Receivables - Net stood at $45368.0 in 2021, then plummeted by 93.44% to $2975.0 in 2022, then surged by 1736154.89% to $51.7 million in 2024, then skyrocketed by 207.0% to $158.6 million in 2025.
  • Its Receivables - Net stands at $158.6 million for Q3 2025, versus $42.9 million for Q2 2025 and $957206.0 for Q1 2025.